$4.06 - 0.10 (-2.404%)

3 month stock price graph

4:00 PM ET on Oct 21, 2016 Pricing delayed 20 minutes

Investors & Media

Investors & Media

Dicerna is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare, inherited diseases involving the liver and for cancers that are genetically defined. The Company is using its proprietary RNA interference (RNAi) technology platform to build a broad pipeline in these therapeutic areas.